Scientific Programme

Please see below for the HIV & Hepatitis in the Americas Scientific Programme 2019!

To view in Spanish, click here

To view in Portugese click here

Thursday 4 April
Friday 5 April
Saturday 6 April

Thursday 4 April

09.00-10.30Latin American Workshop Group


11.00-12.30Industry Symposium

12.30-13.30Lunch and Scientific Posters

13.30-13.45Official Opening and Welcome

13.45-14.45Keynote Lecture

13.45-14.15The Safety of ARVs During First Trimester of Pregnancy
Lynne Mofenson, Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC, USA

14.15-14.45First-line Therapy in the Region
Pedro Cahn, Fundación Huésped, Buenos Aires, Argentina

14.45-15.00Coffee and Scientific Posters

15.00-15.30HPV in HIV

15.00-15.30Keynote Lecture: State of the Art for Clinicians
Tim Wilkin, Weill Cornell Medicine, New York, NY, USA

15.30-16.30Oral Papers

15.30-16.15Oral Papers

16.15-16.30Panel Discussion

16.30-17.00Coffee and Scientific Posters

17.00-18.30Industry Symposium

18.30-19.15Welcome Reception and Posters

Back to the top of the page

Friday 5 April

09.00-10.30Industry Symposium

10.30-11.00Coffee and Scientific Posters

11.00-12.30On the Path to Ending TB in the Americas
Chair: Monica Thormann, Salvador B. Gautier Hospital, Santo Domingo, Dominican

11.00-11.30Keynote Lecture: Challenges of TB/HIV in the region
Alicia Piñeirúa‐Menendez, Clinica Especializada Condesa Iztapalapa, Mexico City,

11.30-12.15Oral Papers and discussion

12.15-12.45Keynote Lecture: Treatment and Prevention in Adolescents and their
Transition to Adult Care

Allison Agwu, Johns Hopkins Pediatric, Baltimore, MD, USA

12.45-13.45Lunch and Scientific Posters

13.45-14.15Keynote Lecture: The Future of ART and Cure Update
Daniel Kuritzkes, Harvard Medical School and Brigham Women’s Hospital, Boston, MA,

14.15-15.10HIV and Ageing
Peter Hunt, University of California San Francisco, San Francisco, CA, USA

14.35-14.55Clinical context, implications and perspectives


15.10-16.30Hepatitis: Status Update and What’s New?

15.10-15.30Hepatitis B: is cure on the agenda?
Mark Nelson, Imperial College, London, UK

15.30-15.50Non-viral liver disease and HIV/NASH
Mario Pessoa, University of Sao Paulo, Sao Paulo, Brazil

15.50-16.10Hepatitis C eradication: is it for real in this day and age of economic constriction?
Jorge L Santana, University of Puerto Rico School of Medicine, San Juan, Puerto Rico

16.10-16.30Panel Discussion

16.30-17.00CROI 2019 Review
Luis Soto Ramirez, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán,
Mexico City, Mexico

17.00-17.30Coffee and Scientific Posters

17.00-18.00Industry Symposium

18.00-18.45Reception and Scientific Posters

Back to the top of the page

Saturday 6 April

09.00-10.30Challenging Cases in HIV Prevention and Management
In collaboration with the International Antiviral Society-USA (IAS-USA)

09.00-09.30ART sequencing (DTG first-line and DTG second-line)

09.30-10.00Fungal disease, probably crypto

10.00-10.30PEP to PrEP

10.30-11.00Coffee and Scientific Posters

11.00-12.30Public Health HIV Programs of Latin America and the Caribbean Moving
Beyond NNRTI-based First-line Regimens

Session in collaboration with the Pan American Health Organization (PAHO)

11.00-11.20Landscape of current HIV care and treatment policies and practices

11.20-11.30The role of civil society in the evolving HIV treatment programs: Lessons
learned and recommendations

11.30-11.45ART and sexual and reproductive health of women living with HIV in the Americas:
challenges and opportunities

Rebecca Zash, Reproductive Health, Harvard University Center for AIDS Research,
Cambridge, MA, USA

11.45-12.00The emerging threat of HIV drug resistance: findings to accelerate transition
Santiago Avila-Rios, Center for Research in Infectious Diseases, Mexico City, Mexico

12.00-12.15Experience with dolutegravir in first-line treatment in Brazil: the first 100,000

12.15-12.30Panel Discussion

12.30-13.30Lunch and Scientific Posters

13.30-15.00Barriers and Facilitators to Early Treatment and PrEP Implementation in the Region
In collaboration with the International AIDS Society

13.30-13.55Where are we now? Overview update
Kenneth Mayer, Boston, MA, USA

13.55-14.05The Brazilian Implementation Plan
Adele Schwartz Benzaken, Brazilian Ministry of Health, Brasilia, Brazil

14.05-14.15From clinical trials to clinical reality: the Peruvian experience
Carlos Cáceres, Cayetano Heredia University, and Institute of Studies in Health,
Sexuality and Human Development, Lima, Peru

14.15-14.25Sexual Health Clinics and PrEP implementation in Buenos Aires
Marcelo Losso, HIV Unit, Hospital Ramos Mejia, Buenos Aires, Argentina

14.25-14.35PrEP implementation in transgender women
Florentino Badial, School of Medicine, Universidad Nacional Autónoma de México,
Mexico City, Mexico


15.00-15.10Closing Remarks and Depart